IRF Admission denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for irf admission are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Issued a "Not FDA-Approved" Denial for IRF Admission — and Why It Is Erroneous

Inpatient Rehabilitation Facility (IRF) admission is a CMS-regulated, Medicare-certified level of post-acute care — it is a facility and care-setting designation, not a drug or device that requires FDA approval. A "not FDA-approved" denial applied to an IRF stay almost certainly reflects a claim coding error, a wrong policy applied, or an administrative processing mistake. FDA approval is not a relevant coverage criterion for a facility-based level of care. This denial should be challenged on administrative grounds before a full medical-necessity analysis is even necessary.

## Federal Appeal Rights

Any adverse benefit determination — regardless of its stated basis — triggers your full federal appeal rights. Under ACA §2719, you are entitled to an internal appeal followed by an independent external review by a certified IRO. Under ERISA §503 (for employer-sponsored plans), you have the right to a full-and-fair review and access to the specific criteria applied. The external review window is generally 4 months from the final internal denial. If the patient is hospitalized and facing urgent discharge, request expedited review.

## Concrete Appeal Steps

1. Obtain the full denial letter and identify the specific UHC policy cited as the basis for the "not FDA-approved" determination. 2. Contact UHC member services and request clarification of which coverage policy governs inpatient rehabilitation facility stays under your plan. Ask them to identify why an FDA-approval criterion was applied. 3. File a formal internal appeal challenging the application of an FDA-approval standard to a facility-level care setting, citing that IRF is regulated and certified by CMS, not the FDA. 4. If the internal appeal is denied, request independent external review immediately.

## Documentation to Gather

• Plan documents: Your Summary of Benefits and Coverage and full plan document identifying the inpatient rehabilitation benefit and the criteria that govern it — these should reference CMS or clinical criteria, not FDA approval.
• CMS certification documentation: The IRF facility's CMS certification as an inpatient rehabilitation facility. This establishes the regulatory framework that governs IRF care.
• Treating physician certification and clinical notes: Documenting the patient's diagnosis, functional deficits, and medical necessity for IRF-level care — included to address any secondary medical-necessity review that may follow correction of the primary error.
• Claim and EOB records: To show how the claim was submitted and processed, supporting the argument that the wrong policy was applied.

## Criteria-Mapping Structure

In your appeal letter, directly address the inapplicability of the FDA-approval criterion to an IRF admission. Then, as a secondary argument, provide a complete criterion-by-criterion response to UHC's IRF medical-necessity policy — so that if the administrative error is corrected, the clinical justification is already on record and a second round of review is unnecessary.